Skip to content

Castle Biosciences Inc

CSTL· NasdaqCore metricsCIK 1447362

Medical laboratories28 peers

Last sale
Nov 2, 2026 · -5.82%
Market cap
$1.08B
30.82M shares
Filings
894
$102.89M
Q3 2026+3.7% FY25 yoy
-$4.10M
Q3 2026N/M FY25 yoy
-$2.73M
Q3 2026N/M FY25 yoy
-$15.78M
Q3 2026derived−22.5% FY25 yoy
-$0.13
Q3 2026N/M FY25 yoy
$77.99M
Q3 2026−2.5% FY25 yoy
$1.08B
—
2.9×
2.2×
0.37%
—

Twelve months to Sep 30, 2026 · derived

Price

$34.93+33.99%+$8.86past year
Nov 2, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$344.23MFY 2025
$344.23M0FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$344,229,000reported
FY 20242024-12-31$332,069,000reported
FY 20232023-12-31$219,788,000reported
FY 20222022-12-31$137,039,000reported
FY 20212021-12-31$94,085,000reported
FY 20202020-12-31$62,649,000reported
FY 20192019-12-31$51,865,000reported
FY 20182018-12-31$22,786,000reported

Segments

Products
Revenue by Products, FY2020 to FY2025FY2020Dermatologic · FY2020 · $57.65MOther · FY2020 · $5.00MFY2021Dermatologic · FY2021 · $85.75MOther · FY2021 · $8.33MFY2022Dermatologic · FY2022 · $124.81MNon Dermatologic · FY2022 · $12.23MOther · FY2022 · $12.23MFY2023Dermatologic · FY2023 · $183.38MNon Dermatologic · FY2023 · $36.41MFY2024Dermatologic · FY2024 · $257.00MNon Dermatologic · FY2024 · $75.07MFY2025Dermatologic · FY2025 · $216.37MNon Dermatologic · FY2025 · $127.86M
LineFY2025ShareChange
Dermatologic$216.37M63%−15.8%
Non Dermatologic$127.86M37%+70.3%
Other———
Total$344.23M

From the 10-K filed Feb 26, 2026CSTL

Medical laboratories

Castle Biosciences Inc is the 10th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Castle Biosciences Inc · CIK 1447362 · Engraved from SEC EDGAR